AbbVie traded at $167.88 this Tuesday June 11th, decreasing $2.59 or 1.52 percent since the previous trading session. Looking back, over the last four weeks, AbbVie lost 4.09 percent. Over the last 12 months, its price rose by 21.89 percent. Looking ahead, we forecast AbbVie to be priced at 168.49 by the end of this quarter and at 165.42 in one year, according to Trading Economics global macro models projections and analysts expectations.